166 related articles for article (PubMed ID: 24828537)
1. Comparison of acquisition time and dose for late gadolinium enhancement imaging at 3.0 T in patients with chronic myocardial infarction using Gd-BOPTA.
Doltra A; Skorin A; Hamdan A; Schnackenburg B; Gebker R; Klein C; Nagel E; Fleck E; Kelle S
Eur Radiol; 2014 Sep; 24(9):2192-200. PubMed ID: 24828537
[TBL] [Abstract][Full Text] [Related]
2. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.
Bauner KU; Reiser MF; Huber AM
Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911
[TBL] [Abstract][Full Text] [Related]
3. Ultra low-dose of gadobenate dimeglumine for late gadolinium enhancement (LGE) imaging in acute myocardial infarction: a feasibility study.
Galea N; Francone M; Zaccagna F; Ciolina F; Cannata D; Algeri E; Agati L; Catalano C; Carbone I
Eur J Radiol; 2014 Dec; 83(12):2151-2158. PubMed ID: 25293818
[TBL] [Abstract][Full Text] [Related]
4. Assessment of acute myocardial infarction in man with magnetic resonance imaging and the use of a new paramagnetic contrast agent gadolinium-BOPTA.
Holman ER; van Rossum AC; Doesburg T; van der Wall EE; de Roos A; Visser CA
Magn Reson Imaging; 1996; 14(1):21-9. PubMed ID: 8656987
[TBL] [Abstract][Full Text] [Related]
5. Low-dose gadobenate dimeglumine versus standard-dose gadopentate dimeglumine for delayed contrast-enhanced cardiac magnetic resonance imaging.
Balci NC; Inan N; Anik Y; Erturk MS; Ural D; Demirci A
Acad Radiol; 2006 Jul; 13(7):833-9. PubMed ID: 16777557
[TBL] [Abstract][Full Text] [Related]
6. Low-dose contrast-enhanced magnetic resonance imaging of brain metastases at 3.0 T using high-relaxivity contrast agents.
Huang B; Liang CH; Liu HJ; Wang GY; Zhang SX
Acta Radiol; 2010 Feb; 51(1):78-84. PubMed ID: 19912078
[TBL] [Abstract][Full Text] [Related]
7. Myocardial delayed enhancement using a single dose (0.1 mmol/kg) of gadobenate dimeglumine: contrast resolution versus intraventricular blood and viable myocardium.
Papini GD; Tritella S; Secchi F; Aliprandi A; Di Leo G; Sardanelli F
Radiol Med; 2010 Aug; 115(5):693-701. PubMed ID: 20221713
[TBL] [Abstract][Full Text] [Related]
8. Single-dose gadobutrol in comparison with single-dose gadobenate dimeglumine for magnetic resonance imaging of chronic myocardial infarction at 3 T.
Wildgruber M; Stadlbauer T; Rasper M; Hapfelmeier A; Zelger O; Eckstein HH; Halle M; Rummeny EJ; Huber AM
Invest Radiol; 2014 Nov; 49(11):728-34. PubMed ID: 24872002
[TBL] [Abstract][Full Text] [Related]
9. Comparison of gadobenate dimeglumine (Gd-BOPTA) with gadopentetate dimeglumine (Gd-DTPA) for enhanced MR imaging of brain and spine tumours in children.
Colosimo C; Demaerel P; Tortori-Donati P; Christophe C; Van Buchem M; Högström B; Pirovano G; Shen N; Kirchin MA; Spinazzi A
Pediatr Radiol; 2005 May; 35(5):501-10. PubMed ID: 15678342
[TBL] [Abstract][Full Text] [Related]
10. Detectability of small liver metastases with gadolinium BOPTA.
Runge VM; Lee C; Williams NM
Invest Radiol; 1997 Sep; 32(9):557-65. PubMed ID: 9291044
[TBL] [Abstract][Full Text] [Related]
11. T1 mapping of the myocardium: intra-individual assessment of the effect of field strength, cardiac cycle and variation by myocardial region.
Kawel N; Nacif M; Zavodni A; Jones J; Liu S; Sibley CT; Bluemke DA
J Cardiovasc Magn Reson; 2012 May; 14(1):27. PubMed ID: 22548832
[TBL] [Abstract][Full Text] [Related]
12. Hepatic abscesses. Magnetic resonance imaging findings using gadolinium-BOPTA.
Runge VM; Wells JW; Williams NM
Invest Radiol; 1996 Dec; 31(12):781-8. PubMed ID: 8970881
[TBL] [Abstract][Full Text] [Related]
13. Myocardial Partition Coefficient of Gadolinium: A Pilot Study in Patients With Acute Myocarditis, Chronic Myocardial Infarction, and in Healthy Volunteers.
Teixeira T; Hafyane T; Jerosch-Herold M; Marcotte F; Mongeon FP
Can J Cardiol; 2019 Jan; 35(1):51-60. PubMed ID: 30595183
[TBL] [Abstract][Full Text] [Related]
14. Macrocyclic contrast agents for magnetic resonance imaging of chronic myocardial infarction: intraindividual comparison of gadobutrol and gadoterate meglumine.
Wagner M; Schilling R; Doeblin P; Huppertz A; Luhur R; Schwenke C; Maurer M; Hamm B; Taupitz M; Durmus T
Eur Radiol; 2013 Jan; 23(1):108-14. PubMed ID: 22772150
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of intraaxial enhancing brain tumors on magnetic resonance imaging: intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for visualization and assessment, and implications for surgical intervention.
Kuhn MJ; Picozzi P; Maldjian JA; Schmalfuss IM; Maravilla KR; Bowen BC; Wippold FJ; Runge VM; Knopp MV; Wolansky LJ; Gustafsson L; Essig M; Anzalone N
J Neurosurg; 2007 Apr; 106(4):557-66. PubMed ID: 17432704
[TBL] [Abstract][Full Text] [Related]
16. Gd-BOPTA for assessment of myocardial viability on MRI: changes of T1 value and their impact on delayed enhancement.
Krombach GA; Hahnen C; Lodemann KP; Krämer N; Schoth F; Neizel M; Boeringer J; Günther RW; Kelm M; Kühl H
Eur Radiol; 2009 Sep; 19(9):2136-46. PubMed ID: 19373470
[TBL] [Abstract][Full Text] [Related]
17. Determinants of myocardial response in CMR perfusion imaging using Gd-BOPTA (Multihance).
Gebker R; Paetsch I; Neuss M; Schnackenburg B; Bornstedt A; Jahnke C; Gomaa O; Fleck E; Nagel E
J Cardiovasc Magn Reson; 2005; 7(3):565-72. PubMed ID: 15959969
[TBL] [Abstract][Full Text] [Related]
18. T1 mapping of the myocardium: intra-individual assessment of post-contrast T1 time evolution and extracellular volume fraction at 3T for Gd-DTPA and Gd-BOPTA.
Kawel N; Nacif M; Zavodni A; Jones J; Liu S; Sibley CT; Bluemke DA
J Cardiovasc Magn Reson; 2012 Apr; 14(1):26. PubMed ID: 22540153
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance coronary angiography: comparison between a Gd-BOPTA- and a Gd-DTPA-enhanced spoiled gradient-echo sequence and a non-contrast-enhanced steady-state free-precession sequence.
Nassenstein K; Breuckmann F; Hunold P; Barkhausen J; Schlosser T
Acta Radiol; 2009 May; 50(4):406-11. PubMed ID: 19308763
[TBL] [Abstract][Full Text] [Related]
20. Focal liver lesions: whether a standard dose (0.05 mmol/kg) gadobenate dimeglumine can provide the same diagnostic data as the 0.1 mmol/kg dose.
Nural MS; Gokce E; Danaci M; Bayrak IK; Diren HB
Eur J Radiol; 2008 Apr; 66(1):65-74. PubMed ID: 17555901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
